Journal article

Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer

QT Le, R Fisher, KS Oliner, RJ Young, H Cao, C Kong, E Graves, RJ Hicks, GA McArthur, L Peters, B O'Sullivan, A Giaccia, D Rischin

Clinical Cancer Research | Published : 2012

Abstract

Purpose: Hepatocyte growth factor (HGF) is a hypoxia-induced secreted protein that binds to cMet and regulates interleukin (IL)-8 expression. We evaluated the role of circulating HGF and IL-8 as prognostic and predictive factors for efficacy of tirapazamine (TPZ), a hypoxic cell cytotoxin. Experimental Design: Patients with stages III to IV head and neck cancer were randomized to receive radiotherapy with cisplatin (CIS) or CIS plus TPZ (TPZ/CIS). Eligibility for the substudy included plasma sample availability for HGF and IL-8 assay by ELISA and no major radiation deviations (N = 498). Analyses included adjustment for major prognostic factors. p16 INK4A staining (human papillomavirus surrog..

View full abstract

University of Melbourne Researchers